Skip to main content
All lobbying filings

STANTON PARK GROUP

Lobbying for BRAEBURN PHARMACEUTICALS, INC. · pharmaceutical company

 Filing Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
New Jersey

Official filing document

 Lobbyists on this filing 4
  • JAMES DERDERIAN
    Previously held: Chief of Staff, House Commerce Committee; Legislative Advisor to Rep. Tom Bliley
  • VALERIE HENRY
    Previously held: Legislative Director, Rep. Greg Walden; Legislative Assistant to Sen. John Warner and Sen. Mike Crapo
  • BRYAN WILLIAM WELLS
    Previously held: Policy Advisor, Senator Pat Roberts
  • AISLING MCDONOUGH
    Previously held: Chief of Staff, Rep. Anna Eshoo; Senior Health Advisor, Rep. Anna Eshoo; Policy Coordinator, Energy & Commerce Committee; Legislative Assistant, Sen. Brian Schatz

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Reducing stigma and promoting treatment of opioid use disorder; raising awareness of the benefits of medication assisted therapy (MAT); ensuring patient access to MAT; FDA approval and exclusivity process; patient access to practitioner-administered therapies Reauthorization of the Support Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem